The impact of bariatric surgery on serum tryptophan–kynurenine pathway metabolites

Abstract This study aims to explore the immediate effects of bariatric surgery on serum tryptophan–kynurenine pathway metabolites in individuals with type 2 diabetes and BMI > 30. With the goal of providing insight into the link between tryptophan pathway metabolites, type 2 diabetes, and chronic...

Full description

Bibliographic Details
Main Authors: Kai Tai Derek Yeung, Nicholas Penney, Luke Whiley, Hutan Ashrafian, Matthew R. Lewis, Sanjay Purkayastha, Ara Darzi, Elaine Holmes
Format: Article
Language:English
Published: Nature Portfolio 2022-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-03833-4
_version_ 1818750242806300672
author Kai Tai Derek Yeung
Nicholas Penney
Luke Whiley
Hutan Ashrafian
Matthew R. Lewis
Sanjay Purkayastha
Ara Darzi
Elaine Holmes
author_facet Kai Tai Derek Yeung
Nicholas Penney
Luke Whiley
Hutan Ashrafian
Matthew R. Lewis
Sanjay Purkayastha
Ara Darzi
Elaine Holmes
author_sort Kai Tai Derek Yeung
collection DOAJ
description Abstract This study aims to explore the immediate effects of bariatric surgery on serum tryptophan–kynurenine pathway metabolites in individuals with type 2 diabetes and BMI > 30. With the goal of providing insight into the link between tryptophan pathway metabolites, type 2 diabetes, and chronic obesity-induced inflammation. This longitudinal study included 20 participants. Half were diagnosed with type 2 diabetes. 11 and 9 underwent RYGB and SG respectively. Blood samples were obtained at pre-operative and 3 months post-operative timepoints. Tryptophan and downstream metabolites of the kynurenine pathway were quantified with an ultrahigh-performance liquid chromatography tandem mass spectrometry with electrospray ionisation method. At 3 months post-operation, RYGB led to significant reductions in tryptophan, kynurenic acid and xanthurenic acid levels when compared to baseline. Significant reductions of the same metabolites after surgery were also observed in individuals with T2D irrespective of surgical procedure. These metabolites were significantly correlated with serum HbA1c levels and BMI. Bariatric surgery, in particular RYGB reduces serum levels of tryptophan and its downstream kynurenine metabolites. These metabolites are associated with T2D and thought to be potentially mechanistic in the systemic processes of obesity induced inflammation leading to insulin resistance. Its reduction after surgery is associated with an improvement in glycaemic control (HbA1c).
first_indexed 2024-12-18T04:16:34Z
format Article
id doaj.art-4c7247d8355e42258d43779e7d2ec03d
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-18T04:16:34Z
publishDate 2022-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-4c7247d8355e42258d43779e7d2ec03d2022-12-21T21:21:19ZengNature PortfolioScientific Reports2045-23222022-01-0112111210.1038/s41598-021-03833-4The impact of bariatric surgery on serum tryptophan–kynurenine pathway metabolitesKai Tai Derek Yeung0Nicholas Penney1Luke Whiley2Hutan Ashrafian3Matthew R. Lewis4Sanjay Purkayastha5Ara Darzi6Elaine Holmes7Department of Surgery & Cancer, Imperial College LondonDepartment of Surgery & Cancer, Imperial College LondonDepartment of Surgery & Cancer, Imperial College LondonDepartment of Surgery & Cancer, Imperial College LondonNational Phenome Centre, Imperial College LondonDepartment of Surgery & Cancer, Imperial College LondonDepartment of Surgery & Cancer, Imperial College LondonDepartment of Surgery & Cancer, Imperial College LondonAbstract This study aims to explore the immediate effects of bariatric surgery on serum tryptophan–kynurenine pathway metabolites in individuals with type 2 diabetes and BMI > 30. With the goal of providing insight into the link between tryptophan pathway metabolites, type 2 diabetes, and chronic obesity-induced inflammation. This longitudinal study included 20 participants. Half were diagnosed with type 2 diabetes. 11 and 9 underwent RYGB and SG respectively. Blood samples were obtained at pre-operative and 3 months post-operative timepoints. Tryptophan and downstream metabolites of the kynurenine pathway were quantified with an ultrahigh-performance liquid chromatography tandem mass spectrometry with electrospray ionisation method. At 3 months post-operation, RYGB led to significant reductions in tryptophan, kynurenic acid and xanthurenic acid levels when compared to baseline. Significant reductions of the same metabolites after surgery were also observed in individuals with T2D irrespective of surgical procedure. These metabolites were significantly correlated with serum HbA1c levels and BMI. Bariatric surgery, in particular RYGB reduces serum levels of tryptophan and its downstream kynurenine metabolites. These metabolites are associated with T2D and thought to be potentially mechanistic in the systemic processes of obesity induced inflammation leading to insulin resistance. Its reduction after surgery is associated with an improvement in glycaemic control (HbA1c).https://doi.org/10.1038/s41598-021-03833-4
spellingShingle Kai Tai Derek Yeung
Nicholas Penney
Luke Whiley
Hutan Ashrafian
Matthew R. Lewis
Sanjay Purkayastha
Ara Darzi
Elaine Holmes
The impact of bariatric surgery on serum tryptophan–kynurenine pathway metabolites
Scientific Reports
title The impact of bariatric surgery on serum tryptophan–kynurenine pathway metabolites
title_full The impact of bariatric surgery on serum tryptophan–kynurenine pathway metabolites
title_fullStr The impact of bariatric surgery on serum tryptophan–kynurenine pathway metabolites
title_full_unstemmed The impact of bariatric surgery on serum tryptophan–kynurenine pathway metabolites
title_short The impact of bariatric surgery on serum tryptophan–kynurenine pathway metabolites
title_sort impact of bariatric surgery on serum tryptophan kynurenine pathway metabolites
url https://doi.org/10.1038/s41598-021-03833-4
work_keys_str_mv AT kaitaiderekyeung theimpactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT nicholaspenney theimpactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT lukewhiley theimpactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT hutanashrafian theimpactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT matthewrlewis theimpactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT sanjaypurkayastha theimpactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT aradarzi theimpactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT elaineholmes theimpactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT kaitaiderekyeung impactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT nicholaspenney impactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT lukewhiley impactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT hutanashrafian impactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT matthewrlewis impactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT sanjaypurkayastha impactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT aradarzi impactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites
AT elaineholmes impactofbariatricsurgeryonserumtryptophankynureninepathwaymetabolites